SYNOVIAL SARCOMA

SYNOVIAL SARCOMA was reported 95 times

These drug classes are most commonly taken by patients reporting SYNOVIAL SARCOMA:

# Drug Count
0 Alkylating Drug [EPC] 15
1 Platinum-based Drug [EPC] 11
2 Folate Analog Metabolic Inhibitor [EPC] 9
3 Topoisomerase Inhibitor [EPC] 9
4 Kinase Inhibitor [EPC] 6
5 Integrin Receptor Antagonist [EPC] 5
6 Interferon beta [EPC] 4
7 Microtubule Inhibitor [EPC] 4
8 Nonsteroidal Anti-inflammatory Drug [EPC] 3
9 Penem Antibacterial [EPC] 3
10 Proton Pump Inhibitor [EPC] 3
11 Antirheumatic Agent [EPC] 2
12 Aromatase Inhibitor [EPC] 2
13 Estrogen [EPC] 2
14 Parathyroid Hormone Analog [EPC] 2
15 Thalidomide Analog [EPC] 2
16 Tumor Necrosis Factor Blocker [EPC] 2
17 Vitamin B12 [EPC] 2
18 Vitamin C [EPC] 2
19 Vitamin D [EPC] 2
20 Acetylcholine Release Inhibitor [EPC] 1
21 Amide Local Anesthetic [EPC] 1
22 Antisense Oligonucleotide [EPC] 1
23 Benzodiazepine [EPC] 1
24 CD20-directed Cytolytic Antibody [EPC] 1
25 CD52-directed Cytolytic Antibody [EPC] 1
26 Calcium [EPC] 1
27 Central alpha-2 Adrenergic Agonist [EPC] 1
28 Corticosteroid [EPC] 1
29 Fluoroquinolone Antibacterial [EPC] 1
30 Interleukin-23 Antagonist [EPC] 1
31 Janus Kinase Inhibitor [EPC] 1
32 Leukocyte Growth Factor [EPC] 1
33 Neuromuscular Blocker [EPC] 1
34 Osmotic Laxative [EPC] 1
35 Potassium Salt [EPC] 1
36 RANK Ligand Inhibitor [EPC] 1
37 Retinoid [EPC] 1
38 Rifamycin Antibacterial [EPC] 1
39 Selective T Cell Costimulation Modulator [EPC] 1
40 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
41 Thiazide Diuretic [EPC] 1
42 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
43 Xanthine Oxidase Inhibitor [EPC] 1